Pathologic Response Rate After Concomitant Neo-Adjuvant Radiotherapy And Chemotherapy For Adenocarcinoma Of The Uterine CervixOlivier Poujade, Fabien Reyal, Philippe Morice et al.|International Journal of Gynecological Cancer|2010Cited by 23
Ovarian Real-World International Consortium (ORWIC): A multicentre, real-world analysis of epithelial ovarian cancer treatment and outcomesSue Cheeseman, Geoff Hall, Paul Kubelac et al.|Frontiers in Oncology|2023Cited by 8
Benefit of the addition of hormone therapy to neoadjuvant anthracycline-based chemotherapy for breast cancer: comparison of predicted and observed pCRDaniele Generali, Albane Frati, Silvia Paola Corona et al.|Journal of Cancer Research and Clinical Oncology|2018Cited by 5
Advanced High-Grade Serous Ovarian Cancer Treated With Intensive Cytoreductive Surgery And Chemotherapy: Prognostic Impact Of Lymph Node Involvement: Analysis Of The French National ESME-Unicancer DatabaseCécile Loaec, Barnabé Bouvarel, S. Le Bars et al.|International Journal of Gynecological Cancer|2025Cited by 0
Advanced high-grade serous ovarian cancer treated with intensive cytoreductive surgery and chemotherapy: prognostic impact of lymph node involvement: analysis of the French national ESME-Unicancer databaseS. Le Bars, Cécile Loaec, Catherine Guérin-Charbonnel et al.|European Journal of Surgical Oncology|2026Cited by 0